Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches

The basic principle that deeper therapeutic responses lead to better clinical outcomes in cancer has emerged technologies capable of detecting rare residual tumor cells. The need for ultra-sensitive approaches for minimal residual disease (MRD) detection is particularly evident in Multiple Myeloma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostopoulos, Ioannis V., Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Tsitsilonis, Ourania E., Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267070/
https://www.ncbi.nlm.nih.gov/pubmed/32537439
http://dx.doi.org/10.3389/fonc.2020.00860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267070/
https://www.ncbi.nlm.nih.gov/pubmed/32537439
http://dx.doi.org/10.3389/fonc.2020.00860

Ejemplares similares